Ischemic Stroke with Anticoagulant Protein C Deficiency
Abstract
Ischemic stroke is a circulatory disorder in brain is caused by reduced or stopped blood flow in some areas of brain. It can be caused by thrombotic lesions resulting from atherosclerosis and by emboli that have detached from the lesions atherosclerosis in the heart or cerebral arteries. Ischemic stroke category consists of emboli and lacunae. Characteristic profile clinical manifestations of acute embolic stroke are sudden onset with maximal neurologic deficits. Embolic often originate from heart or from ulcerative carotid plaques. Atrial fibrillation is a predisposing factor for cardiac thrombus, associated with six times of risk increase in strokes. The patient had a diagnosis with a clinical description of a history of post cerebrovascular disorder non hemorrhagic (CVD-NH/ischemic stroke) with hypercoagulable state from an outpatient clinic on April 13th, 2016 for examination antithrombin III (AT III), protein C, protein S, ACA IgG, ACA IgM, fibrinogen, D-dimer, and INR.
References
Aucutt-Walter, N., Jewels, V., & Huang, D. Y. (2009). Neurology. Chapel Hill: A John Wiley & Sons, Ltd, Publications.
Brummel-Ziedins, K. E., Orfeo, T., Everse, S. J., & Mann, K. G. (2014). Blood coagulation and fibrinolysis. Philadelphia: Lippincott Williams & Wilkins.
Caplan, L. R., & Liebeskind, D. S. (2016). Pathology, anatomy, and pathophysiology of stroke. Cambridge: Cambridge University Press.
Goldenberg, N. A., & Manco-Johnson, M. J. (2008). Protein C deficiency. Haemophilia.
Green, D. (2003). Thrombophilia and Stroke. Top Stroke Rehabil, 10(3), 21-33.
Kottke-Marchant, K., & Comp, P. (2002). Laboratory issues in diagnosing abnormalities of protein C, thrombomodulin, and endothelial cell protein C receptor. Arch Pathol Lab med.
Mosnier, L. O., & Griffin, J. H. (2013). Protein C, protein S, thrombomodulin, and the endothelial protein C receptor pathways. Philadelphia: Lippincott Williams & Wilkins.
Pruthi, R. K., & Heit, J. A. (2009). Laboratory evaluation and thrombophilia. Chapel Hill: A John Wiley & Sons, Ltd, Publications.
Rahemtullah, A., & Van Cott, E. M. (2007). Hypercoagulation testing in Ischemic Stroke. Arch Pathol Lab Med, 131, 890-901.
Schick, P. (2010). Hereditary and Acquired Hypercoagulability. Retrieved from: https://emedicine.medscape.com/article/211039. p.s. 1-6.
Setiabudy, R. D. (2012). Hyperhomocysteinemia. Jakarta: FKUI Publishing House.
Setiabudy, R. D. (2007). Molecular Risk Factors for Thrombosis. Jakarta: FKUI Publishing House.
Setiabudy, R. D. (2007). Laboratory Examination in Acute Stroke. Jakarta: FKUI Publishing House.
Setiabudy, R. D., & Widjahakim, W. (2007). Activated Protein C Resistance. Jakarta: FKUI Publishing House.
Sutanto, I., & Setiabudy, R. D. (2007). Relationship between Laboratory Abnormalities with thrombosis. Jakarta: FKUI Publishing House.
Watson, H. G., & Robertson, B. J. (2010). Antiphospholipid syndrome. Chapel Hill: A John Wiley & Sons, Ltd, Publications.
Williams, J. L. (2016). Secondary hemostasis and fibrinolysis. London: Pearson Education Limited.
Setiabudy, R. D. (2007). Laboratory Examination on Deep Vein Thrombosis (DVT). Jakarta: Balai FKUI Publisher.
Williams, J. L. (2016). Thrombophilia. London: Pearson Education Limited.
Wirawan, R. (2007). Laboratory Examination for Monitoring Oral Anticoagulants. Jakarta: Balai FKUI Publisher.
Copyright (c) 2023 International Journal of Science and Society
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
.png)
.jpg)
.png)
.png)
.png)
.png)
1.png)
.jpg)
-modified.png)
-modified.png)
-modified.png)
